4-[6-chloro-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]-N-cyclopropyl-3-methoxybenzamide;N-cyclopropyl-4-[6-(3-fluorophenyl)sulfanyl-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]-3-hydroxybenzamide
C45H40ClF7N10O4S — CID 157230721
Data last refreshed: (MolForge compound catalog, from PubChem)
About 4-[6-chloro-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]-N-cyclopropyl-3-methoxybenzamide;N-cyclopropyl-4-[6-(3-fluorophenyl)sulfanyl-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]-3-hydroxybenzamide
4-[6-chloro-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]-N-cyclopropyl-3-methoxybenzamide;N-cyclopropyl-4-[6-(3-fluorophenyl)sulfanyl-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]-3-hydroxybenzamide (PubChem CID 157230721) has the molecular formula C45H40ClF7N10O4S and a molecular weight of 985.39 g/mol. Its IUPAC name is 4-[6-chloro-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]-N-cyclopropyl-3-methoxybenzamide;N-cyclopropyl-4-[6-(3-fluorophenyl)sulfanyl-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]-3-hydroxybenzamide.
Molecular Properties
| Compound Name | 4-[6-chloro-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]-N-cyclopropyl-3-methoxybenzamide;N-cyclopropyl-4-[6-(3-fluorophenyl)sulfanyl-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]-3-hydroxybenzamide |
|---|---|
| PubChem CID | 157230721 |
| Molecular Formula | C45H40ClF7N10O4S |
| Molecular Weight | 985.39 g/mol |
| Exact Mass | 984.25 |
| IUPAC Name | 4-[6-chloro-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]-N-cyclopropyl-3-methoxybenzamide;N-cyclopropyl-4-[6-(3-fluorophenyl)sulfanyl-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]-3-hydroxybenzamide |
| SMILES | COc1cc(C(=O)NC2CC2)ccc1-c1cnc2c(NCCC(F)(F)F)cc(Cl)nn12.O=C(NC1CC1)c1ccc(-c2cnc3c(NCCC(F)(F)F)cc(Sc4cccc(F)c4)nn23)c(O)c1 |
| InChI | InChI=1S/C25H21F4N5O2S.C20H19ClF3N5O2/c26-15-2-1-3-17(11-15)37-22-12-19(30-9-8-25(27,28)29)23-31-13-20(34(23)33-22)18-7-4-14(10-21(18)35)24(36)32-16-5-6-16;1-31-16-8-11(19(30)27-12-3-4-12)2-5-13(16)15-10-26-18-14(9-17(21)28-29(15)18)25-7-6-20(22,23)24/h1-4,7,10-13,16,30,35H,5-6,8-9H2,(H,32,36);2,5,8-10,12,25H,3-4,6-7H2,1H3,(H,27,30) |
| InChIKey | AUBJTACBGAEBCT-UHFFFAOYSA-N |
| XLogP | 9.96 |
| TPSA | 172.10 Ų |
| H-Bond Donors | 5 |
| H-Bond Acceptors | 13 |
| Rotatable Bonds | 15 |
| Heavy Atoms | 68 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 985.39 |
| LogP ≤ 5 | 9.96 |
| H-Bond Donors ≤ 5 | 5 |
| H-Bond Acceptors ≤ 10 | 13 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 157230721 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.